Site Map
Contact Us
Disclaimer
Search
LATEST NEWS
2012, January 10
D-Pharm will receive up to $7.65 million in expanded strategic cooperation agreement with Wanbang Biopharmaceuticals –PR in Hebrew
2011, October 31
D-Pharm announces expected date of interim report for the DP-b99 Acute Ischemic Stroke Study, MACSI.
2011, October 31
Hebrew PR (use IE browser) “D-Pharm announces expected date of interim report for the DP-b99 Acute Ischemic Stroke Study, MACSI"
DP-b99 a new treatment for acute stroke patients – short film English
Company Profile
Corporate Strategy
The Directors
Key Management
Therapeutic Focus & Market Size
Product Pipeline
Clinical Trials
Technologies
Patents
Reports & Regulatory Announcements
Calendar
Presentation & Factsheet
Advisors & Investors Contacts
FAQ
Latest News
Archived News
W. Europe
Israel